Our group's research is focused on developing new strategies for a more effective and selective treatment of cancer. We study the antitumour activity of new metal-based chemical agents designed to exert a toxic action on cancer cells that can be controlled by light (photochemotherapy), so that they display a selective activity on tumours with minimal effects on healthy cells. We are also developing peptides and carrier proteins that can selectively target these compounds and other chemotherapeutic drugs to tumours. We have recently started to work with nanoparticles to encapsulate chemotherapeutic agents and transport them more efficiently and safely to tumours.
Our projects have a strong multidisciplinary component, and include members from the Departments of Biology and Chemistry at the University of Girona. Our group also incorporates two medical doctors as advisors, with the aim of carrying out more translational research aimed at real needs in clinical practice. In addition, we have collaborators who are doctors and professors in the area of Inorganic Chemistry at the University of Castilla-la Manchaand the University of Burgos, with whom we share coordinated projects and jointly design the research to be carried out.
We have a great motivation for the training of new researchers and every year we accept Bachelor's and Master's students to do experimental work in our laboratories, as well as international students under the programmes Erasmus Traineeship.